A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity

Bioorg Med Chem Lett. 2006 Jun 15;16(12):3224-8. doi: 10.1016/j.bmcl.2006.03.043. Epub 2006 Apr 5.

Abstract

Synthetic hybridization of two privileged drug scaffolds, pyrazolone on the one hand and pyrimidine nucleoside on the other, resulted in the generation of two novel 5-substituted pyrimidine nucleosides with potent in vitro antiviral activity against two representative orthopoxviruses, vaccinia virus and cowpox virus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Molecular Structure
  • Nucleosides / chemical synthesis
  • Nucleosides / chemistry*
  • Nucleosides / pharmacology*
  • Orthopoxvirus / drug effects*
  • Orthopoxvirus / physiology*
  • Pyrazolones / chemical synthesis
  • Pyrazolones / chemistry*
  • Pyrazolones / pharmacology*
  • Pyrimidines / chemistry*
  • Structure-Activity Relationship
  • Virus Replication

Substances

  • Antiviral Agents
  • Nucleosides
  • Pyrazolones
  • Pyrimidines
  • pyrimidine